AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Photocure ASA

Report Publication Announcement Nov 6, 2024

3714_rns_2024-11-06_1291661a-aabe-401c-a133-d5970f661f3b.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Photocure ASA: Invitation to presentation of third quarter 2024 financial results

Oslo, Norway, 6 November 2024: Photocure ASA (Photocure, PHO: OSE) will announce the third quarter 2024 financial results on Wednesday 13 November 2024 at 08:00 CET and will present a live webcast at 14:00 CET the same day.

The quarterly report and presentation will be published at 08:00 CET and will be publicly available at www.photocure.com.

The investor presentation will be streamed live and be hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45 CET.

The streaming event is available through

http://channel.royalcast.com/landingpage/hegnarmedia/20241113\_5/

For further information, please contact:

Photocure

Erik Dahl CFO Tel: +47 45055000 Email: [email protected]

Media and IR enquiries: Geir Bjørlo Corporate Communications (Norway) Tel: +47 91540000 Email: [email protected]

About Photocure

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.cysview.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Talk to a Data Expert

Have a question? We'll get back to you promptly.